pharma-company /Medicinal products /Active ingredients

Rx · PZN 12892742

HEMLIBRA 150 mg/ml solution for injection 60mg-0,4ml vial

German trade nameHEMLIBRA 150 mg-ml Injektionslösung 60mg-0,4ml Durchstechflasche

Active ingredientEmicizumabPharmaceutical formSolution for injection/infusion

Available with fluctuations

6.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €2,386

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for HEMLIBRA 150 mg/ml solution for injection 60mg-0,4ml vial.

Review purchasing terms

HEMLIBRA 150 mg/ml solution for injection 60mg-0,4ml vial contains the active ingredient Emicizumab and comes as Solution for injection/infusion. One pack size is recorded (PZN 12892742). The pharma availability index for German wholesale stands at 6.5 out of 10 over the past 30 days – the pack was therefore available with fluctuations.


Availability of HEMLIBRA 150 mg/ml solution for injection 60mg-0,4ml vial fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.